|
RSRC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.018600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.654000E-01 |
| Normal-vs-Stage2 |
6.753400E-01 |
| Normal-vs-Stage3 |
9.567400E-01 |
| Normal-vs-Stage4 |
4.288200E-01 |
| Stage1-vs-Stage2 |
7.949000E-01 |
| Stage1-vs-Stage3 |
8.562400E-01 |
| Stage1-vs-Stage4 |
5.875600E-01 |
| Stage2-vs-Stage3 |
6.777600E-01 |
| Stage2-vs-Stage4 |
6.941800E-01 |
| Stage3-vs-Stage4 |
4.741600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.142000E-01 |
| Normal-vs-AfricanAmerican |
5.123600E-01 |
| Normal-vs-Asian |
5.862600E-01 |
| Caucasian-vs-AfricanAmerican |
4.525600E-01 |
| Caucasian-vs-Asian |
3.606800E-01 |
| AfricanAmerican-vs-Asian |
4.588800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.532200E-01 |
| Normal-vs-Female |
5.658200E-01 |
| Male-vs-Female |
4.384000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.924400E-01 |
| Normal-vs-Extreme_Weight |
7.456800E-01 |
| Normal-vs-Obese |
4.905400E-01 |
| Normal-vs-Extreme_Obese |
6.521600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.813400E-01 |
| Normal_Weight-vs-Obese |
1.879780E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.578400E-01 |
| Extreme_Weight-vs-Obese |
2.728400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.382000E-01 |
| Obese-vs-Extreme_Obese |
3.926000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.276400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.087600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.175800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.432800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.358800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.553700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.030000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.823800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.193610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.987200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.041400E-01 |
| Normal-VS-Type2 PRCC |
3.302000E-02 |
| Normal-VS-KIRP CIMP |
9.947000E-01 |
| Normal-VS-Unclassified PRCC |
9.927800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.84047999999271E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.493600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.137000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.843800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.626300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.912600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.761500E-02 |
| Normal-vs-N1 |
2.754000E-01 |
| Normal-vs-N2 |
8.842400E-01 |
| N0-vs-N1 |
1.000480E-02 |
| N0-vs-N2 |
5.283200E-01 |
| N1-vs-N2 |
5.430600E-01 |
|
|
